Seres Therapeutics
Price & Volume
Stats
See more52W Range | $6.53-$29.98 |
Market Cap | $160.2M |
Shares Short | 984,687 |
Financials
See moreRevenue (12 Mos) | $351,000 |
Revenue Growth (YoY) | -93.4% |
Gross Profit (12 Mos) | -$14.1M |
Diluted EPS | $0.88 |
News
See moreYahoo Finance • 2 days ago
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
Yahoo Finance • 21 days ago
Seres Therapeutics GAAP EPS of $0.94 beats by $0.52, revenue of $0.35M
Yahoo Finance • 28 days ago
Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
About
CEO | Mr. Thomas J. DesRosier Esq., J.D. |
CFO | Ms. Marella Thorell CPA |
Address | 101 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
